New drug combo could spare kidney removal in High-Risk bladder cancer patients
NCT ID NCT06822010
First seen Nov 15, 2025 · Last updated Apr 25, 2026 · Updated 16 times
Summary
This study tests a two-drug treatment for a type of cancer in the upper urinary tract. The goal is to see if giving gemcitabine followed by a gel form of mitomycin can destroy the cancer without needing to remove the kidney. About 28 adults with favorable high-risk tumors will receive the drugs through a tube placed in the kidney. The main measure of success is whether the cancer disappears completely after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.